Asia Pacific Bioinformatics Market to Witness Rapid Expansion at 17% CAGR by 2026

According to MarkNtel Advisors, the Asia-Pacific Bioinformatics Market size is expecting around 17% CAGR during 2021-26. The surging need for advanced computational tools in biological research, various firms providing outsourcing services for bioinformatics, and the burgeoning requirements for integrated bioinformatics in genomic & clinical diagnostics are the prime aspects driving the bioinformatics market in Asia-Pacific.

Moreover, massive funding by both government & private sector organizations across Asia-Pacific in the bioinformatics field is also a prominent aspect fueling the growth of the bioinformatics market. It has resulted in rapid data & technological advancements in bioinformatics services.

Nevertheless, the growing proteomics & genomics and various research activities on drug discovery are other notable aspects expected to create significant growth opportunities for the Bioinformatics Market in Asia-Pacific during 2021-26, further states the research report, "Asia-Pacific Bioinformatics Market Analysis, 2021."

“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Download Sample PDF Copy of this Report: - https://www.marknteladvisors.com/query/request-sample/asia-pacific-bioinformatics-market.html

Asia-Pacific Bioinformatics Market Segmentation Analysis:

By-Products & Services (Platforms(Sequence Analysis, Sequence Alignment, Sequence Manipulation, Structural & Functional Analysis), Knowledge Management Tools (Generalized, Specialized), Services (Data Analysis, Database Management))
By Application (Genomics, Metabolomics, Chemoinformatics & Drug Design, Transcriptomics, Proteomics, Others (Molecular Medicine, Preventive Medicine, etc.))
By Type of Sector (Animal Biotechnology, Environmental Biotechnology (Waste Clean-up/ Bioremediation, Alternative Energy Sources), Agriculture Biotechnology (Nutritional Quality Improvement, Biodiversity Informatics, Improvement of Plant Resistance, Pest Resistance, Crop Yield Improvement), Forensic Biotechnology, Medical Biotechnology (Reproductive Biotechnology, Gene Therapy, Molecular Medicine, Clinical Diagnostics, Drug Development), Academics)
By Countries(China, Japan, South Korea, Australia, India, Taiwan, South East Asia)

Sequencing Platforms to Acquire the Major Share in the Bioinformatics Market through 2026

The declining prices of sequencing, coupled with various technological advancements, owing to substantial investments by governments & private sectors of different countries across Asia-Pacific in NSG (Next-Generation Sequencing) projects are driving the market for sequencing platforms required for thoroughly analyzing have surged the need for massive data generated through sequencing.

Due to reduced prices of sequencing services, most end-users, including forensic laboratories, pharmaceutical & biotechnology industries, academic & research centers, etc., prefer sequencing platforms to evaluate the massive sequencing data.

Moreover, the mounting number of genome mapping programs is another crucial aspect indicating the surging demand for sequencing platforms across Asia-Pacific in the coming years, which, in turn, would further boost the bioinformatics market.

With Massive Government Funding in Bioinformatics, India to Contribute Significantly to the Market Growth

India has been witnessing rapid growth in the bioinformatics industry. The surging requirements for bioinformatics in drug identification & development, coupled with numerous mergers between the leading biotechnology & IT firms, are driving the market across the country. Moreover, immense government support through favorable incentives and significant investments in R&D activities associated with gene sequencing to early diagnose cancer is another prominent factor projecting remunerative opportunities for the bioinformatics market in India over the forecast years.

Explore the Full Report with Charts, Table of Contents, and List of Figures – https://www.marknteladvisors.com/research-library/asia-pacific-bioinformatics-market.html

Competitive Landscape:

The leading players in the Asia-Pacific Bioinformatics Market include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Perkinelmer, Inc., Qiagen Bioinformatics, Agilent Technologies, Dnastar, Waters Corporation, Sophia Genetics, Partek, Biomax Informatics AG, Wuxi Nextcode, Beijing Genomics Institute (BGI).

Key Questions Answered in the Research Report

What are the current & future trends in the Asia-Pacific Bioinformatics Market?
How has the industry been evolving in terms of geography & service adoption?
How has the competition been shaping across Asia-Pacific, followed by their comparative factorial indexing?
What are the key growth drivers & challenges for the Asia-Pacific Bioinformatics Market?
What are the customer orientation, purchase behavior, & expectations from bioinformatics firms across Asia-Pacific?

Who We Are:

Our team entails professional analysts and researchers who intelligently utilize research techniques to procure detail-driven, unbiased, and reliable data encompassing the industry. We aim to nurture a result-oriented team to offer strategically-moving insights to our clients.

Our fact-based reports allow the user to design their motives, funds, and strategies, with a higher focus on mitigating confusion and bringing forward a clear insight into the industry. It further allows the clients to identify the lucrative opportunities awaiting.

Insights offered by MarkNtel Advisors comprise in-depth information on regional & country-based trends emerging in the industry. The team studies & compiles the prospects, ensuring consistency in reports.

Our services are beyond offering research reports to the clients and further expand into addressing queries while incorporating with them for advice, development, & execution of strategies for exception growth.